Oxford Biomedica Solutions Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Oxford Biomedica Solutions's estimated annual revenue is currently $29.3M per year.(i)
  • Oxford Biomedica Solutions's estimated revenue per employee is $201,000

Employee Data

  • Oxford Biomedica Solutions has 146 Employees.(i)
  • Oxford Biomedica Solutions grew their employee count by 10% last year.

Oxford Biomedica Solutions's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3400%$634MN/A
#2
$57.9M2880%N/AN/A
#3
$2M10-17%N/AN/A
#4
$33.6M16720%N/AN/A
#5
$15.5M77126%N/AN/A
#6
$25.1M1258%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.1M50-2%N/AN/A
#9
$1.8M385-4%$538MN/A
#10
$46.6M232-7%N/AN/A
Add Company

What Is Oxford Biomedica Solutions?

Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.

keywords:N/A

N/A

Total Funding

146

Number of Employees

$29.3M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$33.7M14611%N/A
#2
$34.2M1483%N/A
#3
$66.3M150-7%N/A
#4
$29.3M15220%N/A
#5
$24.7M15535%N/A